Evidence map›Paper›PMID 42239101›Full record

ArticlebioRxiv : the preprint server for biology2026

High-throughput engineering of ligand-activated splicing ribozyme through domain insertion.

August Staubus, Ella Ramamurthy, Anika Gupta, Madison Furnish, Arjun Khakhar, James Chappell

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

August StaubusBiochemistry and Cell Biology Graduate Program, Rice University, Houston, TX, USA.ORCID 0000-0002-0085-815X
Ella RamamurthySystems, Synthetic, and Physical Biology Graduate Program, Rice University, Houston, TX, USA.
Anika GuptaSystems, Synthetic, and Physical Biology Graduate Program, Rice University, Houston, TX, USA.ORCID 0009-0003-1047-7400
Madison FurnishDepartment of Biology, Colorado State University, Fort Collins, Colorado 80525, United USA.
Arjun KhakharDepartment of Biology, Colorado State University, Fort Collins, Colorado 80525, United USA.ORCID 0000-0002-4676-6533
James ChappellDepartment of BioSciences, Rice University, Houston, TX, USA.ORCID 0000-0001-7367-1524

Funding

Elucidating Mechanisms and Design Principles for Chemically Inducible Expression ModulationR35GM155313 · NIGMS · COLORADO STATE UNIVERSITY · PI Arjun Khakhar · 2024 to 2026
$1.2M
NIGMS NIH HHS R35 GM155313
6 · The paper itself

Abstract

Domain insertion is an established method to engineer ligand-mediated control of activity in protein scaffolds. Whether this strategy can be systematically applied to large, structured RNAs remains unclear. In this study, we investigated the feasibility of engineering ligand-activated splicing ribozymes (LASRs) from group I catalytic introns. Using domain-insertion profiling coupled with high-throughput screening, we mapped the nucleotide-resolution landscape of aptamer insertion across the ribozyme and identified sites that support robust ligand-dependent control. We showed LASRs function across multiple kingdoms of life, including diverse species of bacteria and even fungi, and can be used to regulate various genetic outputs. Finally, we integrated LASRs with a genetic recorder that writes information into ribosomal RNA, enabling sequencing-based recovery of intracellular chemical signals from microbial consortia. This work establishes LASRs as an RNA-based inducible control platform for sensing diverse chemical inputs, regulating the expression of diverse genes of interest, and recording intracellular information.

Identifiers

PMID42239101
PMCPMC13228598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.